FAM131B-AS2: A Potential Drug Target and Biomarker (G100507507)

Target Name: FAM131B-AS2

NCBI ID: G100507507

FAM131B-AS2

Other Name(s): Uncharacterized protein LOC100507507 | Uncharacterized LOC100507507 | FAM131B antisense RNA 2 | LOC100507507

FAM131B-AS2: A Potential Drug Target and Biomarker

FAM131B-AS2 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function and structure have been well-studied, and it is known to play a role in several physiological processes in the body. In recent years, researchers have become interested in using FAM131B-AS2 as a drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Drug Target

FAM131B-AS2 has been identified as a potential drug target due to its unique structure and its involvement in several cellular processes that are associated with the development and progression of several diseases. One of the key features of FAM131B-AS2 is its ability to interact with several different proteins, including T-cell receptor alpha chain (TCR伪), nuclear factor kappa B (NF-kappa-B), and integrins 伪6 (伪6).

FAM131B-AS2 has been shown to play a role in the regulation of T-cell development and function, as well as in the regulation of inflammation and immune cell signaling. Several studies have shown that inhibition of FAM131B-AS2 can lead to the regression of cancerous tumors, and that this effect is mediated by its interaction with TCR伪 and NF-kappa-B.

Biomarker

FAM131B-AS2 has also been identified as a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The ability of FAM131B-AS2 to interact with different proteins makes it a promising biomarker for disease diagnosis and treatment.

One of the key advantages of FAM131B-AS2 as a biomarker is its ability to be easily measured and detected in body fluids, such as blood or urine. This makes it a potential source of diagnostic information for diseases that are difficult to diagnose or monitor.

In addition to its potential as a biomarker, FAM131B-AS2 has also been shown to be involved in several disease processes that are associated with the development and progression of neurodegenerative diseases. This suggests that FAM131B-AS2 may be a useful target for therapies aimed at treating these conditions.

Conclusion

In conclusion, FAM131B-AS2 is a protein that has the potential to be a drug target or biomarker for several diseases. Its unique structure and involvement in several cellular processes make it an attractive target for research into the mechanisms of its function and the development of new therapies. Further studies are needed to fully understand the role of FAM131B-AS2 in disease and to determine its potential as a drug or biomarker.

Protein Name: FAM131B Antisense RNA 2

The "FAM131B-AS2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM131B-AS2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets